One more achievement: Qrem Regenerative Technology is a new partner! Skymedical acquired the exclusive rights for the countrywide distribution and marketing of the Qrem Cytokine, the first device that incorporates the Lab-in-a-box technology to obtain autologous serum, rich in cytokines (SARC), from the patient’s own blood.
The Qrem Cytokine is an innovative device that uses a patented biological process to obtain SARC through the patient’s blood. Thus, the serum, which ends up having a natural reaction in the human body, promotes the reduction of inflammation in the joints and activates cartilage regeneration through cytokines. After the first year of treatment, it reduces up to 75% of the pain reported by patients with osteoarthritis.
Qrem Cytokine incorporates an advanced Lab-in-a-Box technology that guarantees the sterility of SARC and allows its to be fast and effective. Furthermore, as it does not contain any drug, SARC does not have the side effects of the current treatments, which act only temporarily against pain.
With this new partnership, Skymedical enhances its vision of staying by the side of health to expand life, ensuring the best medical devices you can trust.